Search
for
Sort by
Research 601–630 of 1000+
- UTILIZAÇÃO DE ISOTRETINOÍNA ORAL NO TRATAMENTO DA ALOPECIA FIBROSANTE FRONTAL: SÉRIE DE CASOS
- UTILIZAÇÃO DE ISOTRETINOÍNA ORAL NO TRATAMENTO DA ALOPECIA FIBROSANTE FRONTAL: SÉRIE DE CASOS
- Rationale and Design of a Novel, Phase 3, External and Synthetic Placebo-Controlled Clinical Trial of Ritlecitinib 50 mg and 100 mg for Alopecia Areata
- Dermatologic Comorbidities Associated with Atopic Dermatitis Towards a Shared Therapeutical Approach: A Narrative Review
- Postępowanie kosmetologiczne w wybranych jednostkach chorobowych : podręcznik dla studentów kosmetologii oraz kierunków medycznych
- Spontaneous complete resolution of alopecia totalis post SARS-CoV-2 infection
- The efficacy and safety of JAK inhibitors for alopecia areata: A systematic review and meta-analysis of prospective studies
- Epigallocatechin-3 Gallate Inhibits STAT-1/JAK2/IRF-1/HLA-DR/HLA-B and Reduces CD8 MKG2D Lymphocytes of Alopecia Areata Patients
- 695 Selectively targeting JAK1 or JAK3 pathway is sufficient to reverse alopecia areata
- Familial aggregation of alopecia areata
- Alopecia areata after dupilumab for atopic dermatitis
- Selective inhibition of JAK3 signaling is sufficient to reverse alopecia areata
- Janus kinase inhibition in Down syndrome: 2 cases of therapeutic benefit for alopecia areata
- A Case of Topical Ruxolitinib Treatment Failure in Alopecia Areata
- 3-Deoxysappanchalcone Promotes Proliferation of Human Hair Follicle Dermal Papilla Cells and Hair Growth in C57BL/6 Mice by Modulating WNT/β-Catenin and STAT Signaling
- Costunolide promotes the proliferation of human hair follicle dermal papilla cells and induces hair growth in C57BL/6 mice
- Maintenance, withdrawal, and re-treatment with ritlecitinib and brepocitinib in patients with alopecia areata in a single-blind extension of a phase 2a randomized clinical trial
- Can we teach old drugs new tricks?—Repurposing of neuropharmacological drugs for inflammatory skin diseases
- The use of topical ruxolitinib 1.5% cream in frontal fibrosing alopecia: A case report
- Treatment of alopecia areata with the janus kinase inhibitor upadacitinib: A retrospective cohort study
- The Relative Efficacy and Safety of Monotherapies for Alopecia Areata: A Network Meta‐Analysis Study
- Retrospective analysis of the application of fumaric acid esters in 13 patients with alopecia areata
- Platelet-rich plasma in the treatment of alopecia areata: A retrospective evaluation of 17 patients
- Potential Treatment of Steroid‐Resistant Alopecia Areata Using Allogeneic Exosomes Derived From Adipose Tissue Mesenchymal Stromal Cells: A Case Report
- 0350 Impact of switching janus kinase inhibitors in the treatment of severe alopecia areata
- BH08 Unprovoked pulmonary emboli in a patient with alopecia areata treated with ritlecitinib: a case report
- 5PSQ-117 Effectiveness of baricitinib in alopecia areata
- Dual improvement of alopecia areata and immune thrombocytopenia with baricitinib: a case report
- P88 Real-world evidence on efficacy and safety of Janus Kinase inhibitors in the treatment of moderate to severe active Ulcerative Colitis
- The role of fractional laser‐assisted drug delivery in enhancing the efficacy of topical bimatoprost solution in the treatment of alopecia areata: An intra‐patient comparative randomized clinical trial